| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |